Neurodegeneration in glaucoma: Progression and calcium-dependent intracellular mechanisms

Neuroscience

Volumn 176, Issue , 2011, Pages 1-11

  Crish, S D ^a   Calkins, D J ^b  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Axon degeneration; Axonal transport; Axonopathy; Intracellular calcium; Neurodegeneration; Retinal ganglion cell

Indexed keywords

CALCIUM ION; VANILLOID RECEPTOR 1;

AGING; APOPTOSIS; CALCIUM CELL LEVEL; CELL SURVIVAL; DENDRITE; DISEASE COURSE; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NERVE FIBER TRANSPORT; NEUROPATHY; NEUROPHYSIOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PERIKARYON; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; RISK FACTOR; SYNAPTOSOME; VISUAL IMPAIRMENT;

CALCIUM; DISEASE PROGRESSION; GLAUCOMA; HUMANS; INTRACELLULAR SPACE; NERVE DEGENERATION;

EID: 79851511882     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.12.036     Document Type: Review

References (159)

1. Abramov A.Y., Scorziello A., Duchen M.R. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurol 2007, 27:1129-1138.
2. Abramson J.J., Zable A.C., Favero T.G., Salama G. Thimerosal interacts with the Ca2+ release channel ryanodine receptor from skeletal muscle sarcoplasmic reticulum. J Biol Chem 1995, 270(50):29644-29647.
3. Adalbert R., Nogradi A., Babetto E., Janeckova L., Walker S.A., Kerschensteiner M., Misgeld T., Coleman M.P. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain 2009, 132(Pt 2):402-416.
4. Anderson D.R., Hendrickson A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol Vis Sci 1974, 13(10):771-783.
5. Anderson D.R., Graham S., Pillunat L. Normal-tension glaucoma. J Glaucoma 2003, 12(2):164-166.
6. Bach M., Hoffmann M.B. Update on the pattern electroretinogram in glaucoma. Optom Vis Sci 2008, 85(6):386-395.
7. Baltan S., Inman D.M., Danilov C.A., Morrison R.S., Calkins D.J., Horner P.J. Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration. J Neurosci 2010, 30(16):5644-5652.
8. Baltmr A., Duggan J., Nizari S., Salt T.E., Cordeiro M.F. Neuroprotection in glaucoma-Is there a future role?. Exp Eye Res 2010, 91(5):554-566.
9. Band L.R., Hall C.L., Richardson G., Jensen O.E., Siggers J.H., Foss A.J. Intracellular flow in optic nerve axons: a mechanism for cell death in glaucoma. Invest Ophthalmol Vis Sci 2009, 50(8):3750-3758.
10. Barron M.J., Griffiths P., Turnbull D.M., Bates D., Nichols P. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br J Ophthalmol 2004, 88(2):286-290.
11. Berridge M.J., Lipp P., Bootman M.D. Signal transduction. The calcium entry pas de deux. Science 2000, 287(5458):1604-1605.
12. Boehm A.G., Breidenbach K.A., Pillunat L.E., Bernd A.S., Mueller M.F., Koeller A.U. Visual function and perfusion of the optic nerve head after application of centrally acting calcium-channel blockers. Graefes Arch Clin Exp Ophthalmol 2003, 241(1):34-38.
13. Bosco A., Inman D.M., Steele M.R., Wu G., Soto I., Marsh-Armstrong N., Hubbard W.C., Calkins D.J., Horner P.J., Vetter M.L. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 2008, 49(4):1437-1446.
14. Brady S., Morfini G. A perspective on neuronal cell death signaling and neurodegeneration. Mol Neurobiol 2010, 42(1):25-31.
15. Bredesen D.E., Rao R.V., Mehlen P. Cell death in the nervous system. Nature 2006, 443(7113):796-802.
16. Buckingham B.P., Inman D.M., Lambert W., Oglesby E., Calkins D.J., Steele M.R., Vetter M.L., Marsh-Armstrong N., Horner P.J. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci 2008, 28(11):2735-2744.
17. Bultynck G., Szlufcik K., Kasri N.N., Assefa Z., Callewaert G., Missiaen L., Parys J.B., De Smedt H. Thimerosal stimulates Ca2+ flux through inositol 1,4,5-trisphosphate receptor type 1, but not type 3, via modulation of an isoform-specific Ca2+-dependent intramolecular interaction. Biochem J 2004, 381:87-96.
18. Burgoyne C.F., Downs J.C., Bellezza A.J., Suh J.K., Hart R.T. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 2005, 24(1):39-73.
19. Cakatay U., Telci A., Kayali R., Tekeli F., Akcay T., Sivas A. Relation of oxidative protein damage and nitrotyrosine levels in the aging rat brain. Exp Gerontol 2001, 36:221-229.
20. Calkins D.J., Horner P.J., Roberts R., Gradianu M., Berkowitz B.A. Manganese-enhanced MRI of the DBA/2J mouse model of hereditary glaucoma. Invest Ophthalmol Vis Sci 2008, 49(11):5083-5088.
21. Chan S.L., Mattson M.P. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 1999, 58(1):167-190.
22. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005, 6(11):889-898.
23. Coleman M.P., Perry V.H. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci 2002, 25(10):532-537.
24. Conforti L., Adalbert R., Coleman M.P. Neuronal death: where does the end begin?. Trends Neurosci 2007, 30(4):159-166.
25. Corredor R.G., Goldberg J.L. Electrical activity enhances neuronal survival and regeneration. J Neural Eng 2009, 6(5):055001.
26. Crish S.D., Sappington R.M., Inman D.M., Horner P.J., Calkins D.J. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A 2010, 107(11):5196-5201.
27. Cuchillo-Ibanez I., Seereeram A., Byers H.L., Leung K.Y., Ward M.A., Anderton B.H., Hanger D.P. Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J 2008, 22(9):3186-3195.
28. Danias J., Lee K.C., Zamora M.F., Chen B., Shen F., Filippopoulos T., Su Y., Goldblum D., Podos S.M., Mittag T. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthalmol Vis Sci 2003, 44(12):5151-5162.
29. Day M., Wang Z., Ding J., An X., Ingham C.A., Shering A.F., Wokosin D., Ilijic E., Sun Z., Sampson A.R., Mugnaini E., Deutch A.Y., Sesack S.R., Arbuthnott G.W., Surmeier D.J. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006, 9(2):251-259.
30. Esin M.M. Ageing and the brain. J Pathol 2007, 211:181-187.
31. Farkas R.H., Chowers I., Hackam A.S., Kageyama M., Nickells R.W., Otteson D.C., Duh E.J., Wang C., Valenta D.F., Gunatilaka T.L., Pease M.E., Quigley H.A., Zack D.J. Increased expression of iron-regulating genes in monkey and human glaucoma. Invest Ophthalmol Vis Sci 2004, 45(5):1410-1417.
32. Feissner, et al. Crosstalk signaling between mitochondrial Ca2+ and ROS. Front Biosci 2009, 14:1197-1218.
33. Feng W., Liu G., Allen P.D., Pessah I.N. Transmembrane redox sensor of ryanodine receptor complex. J Biol Chem 2000, 275(46):35902-35907.
34. Ferreira S.M., Lerner S.F., Brunzini R., Evelson P.A., Llesuy S.F. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004, 137(1):62-69.
35. Ferreira S.M., Lerner S.F., Brunzini R., Reides C.G., Evelson P.A., Llesuy S.F. Time course changes of oxidative stress markers in a rat experimental glaucoma model. Invest Ophthalmol Vis Sci 2010, 51(9):4635-4640.
36. Filippopoulos T., Danias J., Chen B., Podos S.M., Mittag T.W. Topographic and morphologic analyses of retinal ganglion cell loss in old DBA/2NNia mice. Invest Ophthalmol Vis Sci 2006, 47(5):1968-1974.
37. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004, 185:232-240.
38. Fu Q.L., Li X., Shi J., Xu G., Wen W., Lee D.H., So K.F. Synaptic degeneration of retinal ganglion cells in a rat ocular hypertension glaucoma model. Cell Mol Neurobiol 2009, 29(4):575-581.
39. Fuchshofer R., Birke M., Welge-Lussen U., Kook D., Lütjen-Drecoll E. Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest Ophthalmol Vis Sci 2005, 46(2):568-578.
40. Georgiou A.L., Guo L., Cordeiro M.F., Salt T.E. Changes in NMDA receptor contribution to synaptic transmission in the brain in a rat model of glaucoma. Neurobiol Dis 2010, 39(3):344-351.
41. Ghanem A.A., Arafa L.F., El-Baz A. Oxidative stress markers in patients with primary open-angle glaucoma. Curr Eye Res 2010, 35(4):295-301.
42. Goldblum D., Mittag T. Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye. Vis Res 2002, 42(4):471-478.
43. Goñi-Oliver P., Lucas J.J., Avila J., Hernández F. N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation. J Biol Chem 2007, 282(31):22406-22413.
44. Gordon M.O., Beiser J.A., Brandt J.D., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Kass M.A. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002, 120(6):714-720.
45. Gould T.W., Buss R.R., Vinsant S., Prevette D., Sun W., Knudson C.M., Milligan C.E., Oppenheim R.W. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci 2006, 26:8774-8786.
46. Guo L., Tsatourian V., Luong V., Podoleanu A.G., Jackson D.A., Fitzke F.W., Cordeiro M.F. En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma. Br J Ophthalmol 2005, 89(9):1210-1216.
47. Gupta N., Ly T., Zhang Q., Kaufman P.L., Weinreb R.N., Yücel Y.H. Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp Eye Res 2007, 84(1):176-184.
48. Heijl A., Leske M.C., Bengtsson B., Hyman L., Bengtsson B., Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002, 120(10):1268-1279. Early Manifest Glaucoma Trial Group.
49. Hernandez M.R. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res 2000, 19(3):297-321.
50. Hernández-Fonseca K., Massieu L. Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons. J Neurosci Res 2005, 82(2):196-205.
51. Holländer H., Makarov F., Stefani F.H., Stone J. Evidence of constriction of optic nerve axons at the lamina cribrosa in the normotensive eye in humans and other mammals. Ophthal Res 1995, 27(5):296-309.
52. Howell G.R., Libby R.T., Jakobs T.C., Smith R.S., Phalan F.C., Barter J.W., Barbay J.M., Marchant J.K., Mahesh N., Porciatti V., Whitmore A.V., Masland R.H., John S.W. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol 2007, 179(7):1523-1537.
53. Huang W., Fileta J.B., Dobberfuhl A., Filippopolous T., Guo Y., Kwon G., Grosskreutz C.L. Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proc Natl Acad Sci U S A 2005, 102(34):12242-12247.
54. Huang W., Dobberfuhl A., Filippopoulos T., Ingelsson M., Fileta J.B., Poulin N.R., Grosskreutz C.L. Transcriptional up-regulation and activation of initiating caspases in experimental glaucoma. Am J Pathol 2005, 167(3):673-681.
55. Huang W., Fileta J., Rawe I., Qu J., Grosskreutz C.L. Calpain activation in experimental glaucoma. Invest Ophthalmol Vis Sci 2008, 51(6):3049-3054.
56. Huschenbett J., Zaidi A., Michaelis M.L. Sensitivity of the synaptic membrane Na+/Ca2+ exchanger and the expressed NCX1 isoform to reactive oxygen species. Biochim Biophys Acta 1998, 1374(1-2):34-46.
57. Ishii K., Matsuo H., Fukaya Y., Tanaka S., Sakaki H., Waki M., Araie M. Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation. Invest Ophthalmol Vis Sci 2003, 44(3):1169-1177.
58. Jakobs T.C., Libby R.T., Ben Y., John S.W., Masland R.H. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol 2005, 171(2):313-325.
59. Jellinger K.A. Challenges in neuronal apoptosis. Curr Alzheimer Res 2006, 3:377-391.
60. John S.W., Smith R.S., Savinova O.V., Hawes N.L., Chang B., Turnbull D., Davisson M., Roderick T.H., Heckenlively J.R. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 1998, 39(6):951-962.
61. Johnson M.A., Drum B.A., Quigley H.A., Sanchez R.M., Dunkelberger G.R. Pattern-evoked potentials and optic nerve fiber loss in monocular laser-induced glaucoma. Invest Ophthalmol Vis Sci 1989, 30(5):897-907.
62. Jourdi H., Lu X., Yanagihara T., Lauterborn J.C., Bi X., Gall C.M., Baudry M. Prolonged positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors induces calpain-mediated PSD-95/Dlg/ZO-1 protein degradation and AMPA receptor down-regulation in cultured hippocampal slices. J Pharmacol Exp Ther 2005, 314(1):16-26.
63. Ju W.K., Kim K.Y., Duong-Polk K.X., Lindsey J.D., Ellisman M.H., Weinreb R.N. Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma. Mol Vis 2010, 16:1331-1342.
64. Kashiwagi K., Ou B., Nakamura S., Tanaka Y., Suzuki M., Tsukahara S. Increase in dephosphorylation of the heavy neurofilament subunit in the monkey chronic glaucoma model. Invest Ophthalmol Vis Sci 2003, 44(1):154-159.
65. Kawahara M., Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res Bull 2000, 53(4):389-397.
66. Kerrigan L.A., Zack D.J., Quigley H.A., Smith S.D., Pease M.E. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 1997, 115(8):1031-1035.
67. Kerrigan-Baumrind L.A., Quigley H.A., Pease M.E., Kerrigan D.F., Mitchell R.S. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci 2000, 41(3):741-748.
68. King W.M., Sarup V., Sauvé Y., Moreland C.M., Carpenter D.O., Sharma S.C. Expansion of visual receptive fields in experimental glaucoma. Vis Neurosci 2006, 23(1):137-142.
69. Knobloch M., Mansuy I.M. Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol Neurobiol 2008, 37(1):73-82.
70. Ko M.L., Peng P.H., Ma M.C., Ritch R., Chen C.F. Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic Biol Med 2005, 39(3):365-373.
71. Kong G.Y., Van Bergen N.J., Trounce I.A., Crowston J.G. Mitochondrial dysfunction and glaucoma. J Glaucoma 2009, 18(2):93-100.
72. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000, 405(6784):360-364.
73. Leske M.C., Heijl A., Hussein M., Bengtsson B., Hyman L., Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003, 121(1):48-56. Early Manifest Glaucoma Trial Group.
74. Levin L.A. Relevance of the site of injury of glaucoma to neuroprotective strategies. Surv Ophthalmol 2001, 45(Suppl 3):S243-S249.
75. Libby R.T., Li Y., Savinova O.V., Barter J., Smith R.S., Nickells R.W., John S.W. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet 2005, 1(1):17-26.
76. Lu X., Rong Y., Baudry M. Calpain-mediated degradation of PSD-95 in developing and adult rat brain. Neurosci Lett 2000, 286(2):149-153.
77. Mabuchi F., Aihara M., Mackey M.R., Lindsey J.D., Weinreb R.N. Regional optic nerve damage in experimental mouse glaucoma. Invest Ophthalmol Vis Sci 2004, 45(12):4352-4358.
78. Martin K.R., Quigley H.A., Valenta D., Kielczewski J., Pease M.E. Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma. Exp Eye Res 2006, 83(2):255-262.
79. Mattson M.P., Chan S.L. Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 2003, 34(4-5):385-397.
80. McKinnon S.J., Lehman D.M., Kerrigan-Baumrind L.A., Merges C.A., Pease M.E., Kerrigan D.F., Ransom N.L., Tahzib N.G., Reitsamer H.A., Levkovitch-Verbin H., Quigley H.A., Zack D.J. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 2002, 43(4):1077-1087.
81. McKinnon S.J. Glaucoma: ocular Alzheimer's disease?. Front Biosci 2003, 8:s1140-s1156.
82. McKinnon S.J., Goldberg L.D., Peeples P., Walt J.G., Bramley T.J. Current management of glaucoma and the need for complete therapy. Am J Manag Care 2008, 14(Suppl 1):S20-S27.
83. Minckler D.S., Tso M.O., Zimmerman L.E. A light microscopic, autoradiographic study of axoplasmic transport in the optic nerve head during ocular hypotony, increased intraocular pressure, and papilledema. Am J Ophthalmol 1976, 82(5):741-757.
84. Minckler D.S., Bunt A.H., Johanson G.W. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci 1977, 16(5):426-441.
85. Missiaen L., Taylor C.W., Berridge M.J. Luminal Ca2+ promoting spontaneous Ca2+ release from inositol trisphosphate-sensitive stores in rat hepatocytes. J Physiol 1992, 455:623-640.
86. Mittag T.W., Danias J., Pohorenec G., Yuan H.M., Burakgazi E., Chalmers-Redman R., Podos S.M., Tatton W.G. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci 2000, 41(11):3451-3459.
87. Moreno M.C., Campanelli J., Sande P., Sánez D.A., Keller Sarmiento M.I., Rosenstein R.E. Retinal oxidative stress induced by high intraocular pressure. Free Radic Biol Med 2004, 37(6):803-812.
88. Morfini G.A., Burns M., Binder L.I., Kanaan N.M., LaPointe N., Bosco D.A., Brown R.H., Brown H., Tiwari A., Hayward L., Edgar J., Nave K.A., Garberrn J., Atagi Y., Song Y., Pigino G., Brady S.T. Axonal transport defects in neurodegenerative diseases. J Neurosci 2009, 29(41):12776-12786.
89. Morquette J.B., Di Polo A. Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon?. J Neuroophthalmol 2008, 28(2):144-154.
90. Murchison D., Griffith W.H. Calcium buffering systems and calcium signaling in aged rat basal forebrain neurons. Aging Cell 2007, 6(3):297-305.
91. Nagaraju M., Saleh M., Porciatti V. IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest Ophthalmol Vis Sci 2007, 48(10):4573-4579.
92. Nakazawa T., Nakazawa C., Matsubara A., Noda K., Hisatomi T., She H., Michaud N., Hafezi-Moghadam A., Miller J.W., Benowitz L.I. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 2006, 26(49):12633-12641.
93. Nickells R.W. From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma. Can J Ophthalmol 2007, 42(2):278-287.
94. North R.V., Jones A.L., Drasdo N., Wild J.M., Morgan J.E. Electrophysiological evidence of early functional damage in glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 2010, 51(2):1216-1222.
95. Osborne N.N., Wood J.P., Chidlow G., Casson R., DeSantis L., Schmidt K.G. Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma. Brain Res Bull 2004, 62(6):525-528.
96. Pang I.H., Clark A.F. Rodent models for glaucoma retinopathy and optic neuropathy. J Glaucoma 2007, 16(5):483-505.
97. Pease M.E., McKinnon S.J., Quigley H.A., Kerrigan-Baumrind L.A., Zack D.J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 2000, 41(3):764-774.
98. Porciatti V., Nagaraju M. Head-up tilt lowers IOP and improves RGC dysfunction in glaucomatous DBA/2J mice. Exp Eye Res 2010, 90(3):452-460.
99. Qu J., Wang D., Grosskreutz C.L. Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res 2010, 91(1):48-53.
100. Quigley H.A., Addicks E.M. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci 1980, 19(2):137-152.
101. Quigley H.A., Addicks E.M., Green W.R., Maumenee A.E. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981, 99(4):635-649.
102. Quigley H.A., Nickells R.W., Kerrigan L.A., Pease M.E., Thibault D.J., Zack D.J. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995, 36(5):774-786.
103. Quigley H.A. Neuronal death in glaucoma. Prog Retin Eye Res 1999, 18(1):39-57.
104. Quigley H.A., McKinnon S.J., Zack D.J., Pease M.E., Kerrigan-Baumrind L.A., Kerrigan D.F., Mitchell R.S. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci 2000, 41(11):3460-3466.
105. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006, 90(3):262-267.
106. Reigada D., Lu W., Zhang M., Mitchell C.H. Elevated pressure triggers a physiological release of ATP from the retina: possible role for pannexin hemichannels. Neuroscience 2008, 157(2):396-404.
107. Rodnitzky R.L. Can calcium antagonists provide a neuroprotective effect in Parkinson's disease?. Drugs 1999, 57(6):845-849.
108. Rohn T.T. The role of caspases in Alzheimer's disease; potential novel therapeutic opportunities. Apoptosis 2010, 15(11):1403-1409.
109. Ross J.L., Wallace K., Shuman H., Goldman Y.E., Holzbaur E.L. Processive bidirectional motion of dynein-dynactin complexes in vitro. Nat Cell Biol 2006, 8:562-570.
110. Saleh M., Nagaraju M., Porciatti V. Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 2007, 48(10):4564-4572.
111. Salinas-Navarro M., Jiménez-López M., Valiente-Soriano F.J., Alarcón-Martínez L., Avilés-Trigueros M., Mayor S., Holmes T., Lund R.D., Villegas-Pérez M.P., Vidal-Sanz M. Retinal ganglion cell population in adult albino and pigmented mice: a computerized analysis of the entire population and its spatial distribution. Vis Res 2009, 49(6):637-647.
112. Sappington R.M., Chan M., Calkins D.J. Interleukin-6 protects retinal ganglion cells from pressure-induced death. Invest Ophthalmol Vis Sci 2006, 47(7):2932-2942.
113. Sappington R.M., Calkins D.J. Contribution of TRPV1 to microglia-derived IL-6 and NFkappaB translocation with elevated hydrostatic pressure. Invest Ophthalmol Vis Sci 2008, 49(7):3004-3017.
114. Sappington R.M., Sidorova T., Long D.J., Calkins D.J. TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure. Invest Ophthalmol Vis Sci 2009, 50(2):717-728.
115. Sappington R.M., Carlson B.J., Crish S.D., Calkins D.J. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest Ophthalmol Vis Sci 2010, 51(1):207-216.
116. Saragovi H.U., Hamel E., Di Polo A. A neurotrophic rationale for the therapy of neurodegenerative disorders. Curr Alzheimer Res 2009, 6(5):419-423.
117. Schlamp C.L., Li Y., Dietz J.A., Janssen K.T., Nickells R.W. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 2006, 7:66.
118. Schuettauf F., Quinto K., Naskar R., Zurakowski D. Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model. Vis Res 2002, 42(20):2333-2337.
119. Sehi M, Grewal DS, Feuer WJ, Greenfield DS (in press) The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo. Vis Res, in press.
120. Shea T.B., Yabe J.T., Ortiz D., Pimenta A., Loomis P., Goldman R.D., Amin N., Pant H.C. Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons. J Cell Sci 2004, 117(Pt 6):933-941.
121. Shea T.B., Chan W.K. Regulation of neurofilament dynamics by phosphorylation. Eur J Neurosci 2008, 27(8):1893-1901.
122. Shields M.B. Normal-tension glaucoma: is it different from primary open-angle glaucoma?. Curr Opin Ophthalmol 2008, 9(2):85-88.
123. Siman R., Baudry M., Lynch G. Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease. Proc Natl Acad Sci U S A 1984, 81(11):3572-3576.
124. Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol 1989, 107(2):186-188.
125. Sommer A., Tielsch J.M., Katz J., Quigley H.A., Gottsch J.D., Javitt J., Singh K. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991, 109(8):1090-1095.
126. Son J.L., Soto I., Oglesby E., Lopez-Roca T., Pease M.E., Quigley H.A., Marsh-Armstrong N. Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia 2010, 58(7):780-789.
127. Soto I., Oglesby E., Buckingham B.P., Son J.L., Roberson E.D., Steele M.R., Inman D.M., Vetter M.L., Horner P.J., Marsh-Armstrong N. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci 2008, 28(2):548-561.
128. Spires T.L., Hyman B.T. Neuronal structure is altered by amyloid plaques. Rev Neurosci 2004, 15(4):267-278.
129. Stasi K., Nagel D., Yang X., Ren L., Mittag T., Danias J. Ceruloplasmin upregulation in retina of murine and human glaucomatous eyes. Invest Ophthalmol Vis Sci 2007, 48(2):727-732.
130. Steele M.R., Inman D.M., Calkins D.J., Horner P.J., Vetter M.L. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci 2006, 47(3):977-985.
131. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131(6):1164-1178.
132. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., Goldstein L.S. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307(5713):1282-1288.
133. Stys P.K., Waxman S.G., Ransom B.R. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J Neurosci 1992, 12(2):430-439.
134. Tahzib N.G., Ransom N.L., Reitsamer H.A., McKinnon S.J. Alpha-fodrin is cleaved by caspase-3 in a chronic ocular hypertensive (COH) rat model of glaucoma. Brain Res Bull 2004, 62(6):491-495.
135. Tatton W.G., Chalmers-Redman R.M., Tatton N.A. Apoptosis and anti-apoptosis signalling in glaucomatous retinopathy. Eur J Ophthalmol 2001, 11(Suppl 2):S12-S22.
136. Tatton W., Chen D., Chalmers-Redman R., Wheeler L., Nixon R., Tatton N. Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: anti-apoptosis by alpha-2-adrenergic receptor activation. Surv Ophthalmol 2003, 48(Suppl 1):S25-S37.
137. Tezel G., Hernandez M.R., Wax M.B. In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head. Glia 2001, 34(3):178-189.
138. Tezel G., Yang X., Cai J. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest Ophthalmol Vis Sci 2005, 46(9):3177-3187.
139. Tezel G., Yang X., Luo C., Peng Y., Sun S.L., Sun D. Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest Ophthalmol Vis Sci 2007, 48(2):705-714.
140. Tielsch J.M., Sommer A., Katz J., Royall R.M., Quigley H.A., Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991, 266(3):369-374.
141. Tomita G. The optic nerve head in normal-tension glaucoma. Curr Opin Ophthalmol 2000, 11(2):116-120.
142. Tomita G., Niwa Y., Shinohara H., Hayashi N., Yamamoto T., Kitazawa Y. Changes in optic nerve head blood flow and retrobular hemodynamics following calcium-channel blocker treatment of normal-tension glaucoma. Int Ophthalmol 1999, 23:3-10.
143. Veeranna, Kaji T., Boland B., Odrljin T., Mohan P., Basavarajappa B.S., Peterhoff C., Cataldo A., Rudnicki A., Amin N., Li B.S., Pant H.C., Hungund B.L., Arancio O., Nixon R.A. Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease. Am J Pathol 2004, 165(3):795-805.
144. Vidal-Sanz M., Lafuente M.P., Mayor-Torroglosa S., Aguilera M.E., Miralles de Imperial J., Villegas-Pérez M.P. Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death. Eur J Ophthalmol 2001, 11(Suppl 2):S36-S40.
145. Vosler P.S., Brennan C.S., Chen J. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol 2008, 38(1):78-100.
146. Waldmeier P.C., Tatton W.G. Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?. Drug Discov Today 2004, 9(5):210-218.
147. Wang Z., Khan S., Sheetz M.P. Single cytoplasmic dynein molecule movements: characterization and comparison with kinesin. Biophys J 1995, 69(5):2011-2023.
148. Ward M.W., Rego A.C., Frenguelli B.G., Nicholls D.G. Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. J Neurosci 2000, 20(19):7208-7219.
149. Wax M.B., Tezel G., Yang J., Peng G., Patil R.V., Agarwal N., Sappington R.M., Calkins D.J. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T cell-derived Fas-ligand. J Neurosci 2008, 28:12085-12096.
150. Weber A.J., Harman C.D., Viswanathan S. Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina. J Physiol 2008, 586(Pt 18):4393-4400.
151. Weber A.J., Viswanáthan S., Ramanathan C., Harman C.D. Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury. Invest Ophthalmol Vis Sci 2010, 51(1):327-334.
152. Whitmore A.V., Libby R.T., John S.W. Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes?. Prog Retin Eye Res 2005, 24(6):639-662.
153. Wood J.P., Schmidt K.G., Melena J., Chidlow G., Allmeier H., Osborne N.N. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Exp Eye Res 2003, 76(4):505-516.
154. Yuan L., Neufeld A.H. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000, 32(1):42-50.
155. Zaidi A., Michaelis M.L. Effects of reactive oxygen species on brain synaptic plasma membrane Ca(2+)-ATPase. Free Radic Biol Med 1999, 27(7-8):810-821.
156. Zaja-Milatovic S., Milatovic D., Schantz A.M., Zhang J., Montine K.S., Samii A., Deutch A.Y., Montine T.J. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 2005, 64(3):545-547.
157. Zang D.W., Lopes E.C., Cheema S.S. Loss of synaptophysin-positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS. J Neurosci Res 2005, 79(5):694-699.
158. Zhang J., Wu S.M., Gross R.L. Effects of beta-adrenergic blockers on glutamate-induced calcium signals in adult mouse retinal ganglion cells. Brain Res 2003, 959(1):111-119.
159. Zündorf G., Kahlert S., Bunik V.I., Reiser G. Alpha-Ketoglutarate dehydrogenase contributes to production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ. Neuroscience 2009, 158:610-616.